Michigan: Dupixent (dupilumab) litigation | DrugsMonitor.com

Dupixent (dupilumab) litigation in Michigan (MI): Allegations recap, procedure at a glance, next steps—not legal advice.

dupilumab, atopic dermatitis, asthma, ocular surface disease, keratitis, vision injury, Michigan